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HMOs AND MANAGED CARE IN MALAYSIA: WHAT CAN WE




Managed Care Organisations (MCOs) are now part of the Malaysian medical
landscape. Its proponents believe that it will shift the emphasis of medicine back to
preventive and primary care, increase efficiency as well as control costs. Its
detractors believe that, among other things, it will result in deterioration of quality of
care. This paper discusses the experience of Singapore and the United States with
managed care. It is noted that managed care has not taken off in Singapore.
However, managed care is the dominant mode of organisation of healthcare services
in the United States. Factors likely to affect the growth of managed care in Malaysia
are discussed. Whatever its future here, useful innovations from managed care such
as clinical practice guidelines, use of formularies and generic drugs etc. can possibly
be adopted for Malaysia. Nevertheless, there is a need for proper regulation of
Malaysian MCOs.
INTRODUCTION
“Managed Care” can be defined as healthcare services supplied by or through
organisations that also take active steps to influence the care-seeking behaviour of
patients (“healthcare consumers”) and the care-providing behaviour of doctors and
other health professionals (“healthcare providers”)(Robinson and Steiner, 1998)
Two major goals of managed care are:
• To encourage appropriate utilisation of health services by consumers, e.g.,
to reduce the number of unnecessary visits to the doctor, to influence
patients with minor ailments to see a General Practitioner rather than a
specialist
• To encourage appropriate supply of health services by providers, e.g., to
reduce supplier-induced demand (Folland et al., 1993)
Proponents of managed care believe that it would shift the emphasis of
medicine back to preventive and primary care, increase rationality and efficiency in
the healthcare system, promote the provision of medically necessary care instead of
overtreatment and overprescription of drugs, and help to control healthcare cost
inflation.
*  International Medical University
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MANAGED CARE ORGANISATIONS (MCOS) IN THE UNITED STATES
Managed care began with prepaid group practices which first appeared in the United
States in the late 1920s (Raymond, 1994). These prepaid group practices allowed
healthcare consumers to contract for the supply of a fixed range of services with a
group of providers. The providers were paid a fixed fee per enrollee in advance. This
form of payment is known as “capitation”.
The introduction of the Medicare and Medicaid programmes in 1965
contributed to the problem of accelerating healthcare costs (Feldstein, 1979). The
result was a revival of interest in prepaid group practice as a possible solution to
rising healthcare costs. This culminated in the passage of the Health Maintenance
Organisation Act (HMO Act) in 1973. This Act was designed to encourage the
growth of Health Maintenance Organisations (an early type of MCO) so as to
increase competition in the health services sector of the American economy (Davis et
al., 1990)
 The HMO was followed by other kinds of MCOs such as the PPO (Preferred
Provider Organisation), IPA (Independent Practice Association), POS (Point of
Service plan) and so on. MCOs are constantly evolving. Hence, variants and new
types of managed care organisations continue to make their appearance in America.
MCO growth was slow during the 1970s. However, in recent years, MCOs
have proliferated and have become a dominant part of the medical landscape in the
United States. In 1997, 92% of all American doctors held at least one contract with
an MCO (Washington Post, April 5, 1999)
According to the National Center for Policy Analysis (an American think
tank), the Investor’s Business Daily reported in June 1998 that out of a total U.S.
population of about 286 million, approximately 41 million were not covered by any
kind of health insurance. The rest were covered by public programmes such as
Medicare or Medicaid, plans for government employees, or by private health
insurance. It should be noted that more than 80% of all Americans with employer-
sponsored health insurance were enrolled with MCOs (National Center for Policy
Analysis, 1998). Lately, those who are covered by Medicare (the elderly) or
Medicaid (the medically indigent) are being moved into specially-designed Medicare
and Medicaid MCOs.
MANAGED CARE IN SINGAPORE AND MALAYSIA
The first Singaporean MCO was established in 1992 with tacit support from the
Government. Individual enrollees were allowed to use funds from their Medisave
account to pay for the cost of enrolment with the MCO. Furthermore, individual
enrollees as well as group enrollees were allowed to use Medisave to pay the
hospitalisation co-payment fee should they be treated as an in-patient (NTUC
INCOME Insurance Co-operative Limited, Managed Healthcare System)
Currently, there are about 10 MCOs in Singapore. The biggest MCO has an
enrolment of 22,000 (Phua, 1999). If one assumes that each MCO has 20,000
enrollees, this would amount to a total MCO enrolment of 200,000. Hence, out of a
Buletin Kesihatan Masyarakat Isu Khas 2000                                                          169
total population of about 3.5 million, not more than 5.7% of the population is covered
by an MCO. Therefore, one can conclude that although MCOs have been in existence
in Singapore for almost a decade, it has not become the dominant form of healthcare
organisation there.
In the case of Malaysia, the first MCO became operational in 1995. There are
32 registered MCOs today. In 1997, Malaysian MCOs had a total enrolment of
approximately 300,000 or only about 1.5% of an estimated population of 20 million.
These MCOs covered only about 10% of the private labour force (Pilus,
1999)(Bakar, 1999).
THEORETICAL BENEFITS OF MANAGED CARE
As mentioned earlier, proponents of managed care believe that managed care would
shift the emphasis of medicine to preventive and primary care, increase efficiency in
the healthcare system, promote the provision of medically necessary care and help to
control costs (Robinson and Steiner, 1998).
PREVENTIVE CARE
In contrast to the customary fee-for-service system of provider reimbursement,
prepayment reduces the incentive to overtreat or overprescribe drugs in order to
increase revenue (Glaser, 1970). Instead, in theory, systems of prepayment such as
capitation are likely to influence providers to educate the healthcare consumer to stay
healthy and prevent disease so as to make less use of healthcare services. Steps taken
to prevent disease or to detect disease in the early stages would include things like
healthy lifestyles, proper nutrition, avoidance of tobacco and excessive alcohol
consumption, antenatal care, immunisation, Pap smears and mammograms.
EFFICIENCY
Under managed care, efficiency in the supply of healthcare services is increased
(Folland et al. 1993) because the GP handles minor ailments and also acts as a
“gatekeeper” to more expensive specialist and tertiary care. Direct access to
specialists is restricted in the sense that the patient needs to obtain a referral letter
from the GP first.
The GP also acts as the co-ordinator of care. This prevents the fragmentation
of care and lowers the risk of adverse drug interactions because of polypharmacy
(especially when the patient is being treated for different medical conditions by
different specialists).
MCOs typically encourage providers to prescribe generic drugs and drugs
from a preferred list known as a “formulary”. The use of generic drugs in place of
branded drugs would help to lower the cost of healthcare. MCOs can also use their
bargaining power to negotiate discounts on drug prices from pharmaceutical
companies.
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Increasingly, MCOs encourage providers to follow clinical practice guidelines
and protocols and to practise evidence-based medicine so as to reduce variations in
treatment and to avoid unproven procedures. Managed care can also help to reduce
hospitalisation rates and cut down on lengthy hospital stays through mechanisms
such as ambulatory care, day surgery, utilisation review, etc.
MEDICALLY NECESSARY CARE
On the demand side, MCOs attempt to discourage unnecessary visits to the doctor
through co-payments payable by the healthcare consumer. Co-payments can be
waived for preventive care but increased for elective care. In POS plans, patients are
allowed to go out of plan (e.g. by seeking treatment from a provider who has not
contracted with the MCO) but they have to pay much higher co-payments than if they
had sought treatment from an in-plan provider (Raymond, 1994).
On the supply side, capitation reduces the incentives for overtreatment and
overprescription of drugs. Hospitals which are reimbursed for inpatient care on the
basis of DRGs (Diagnosis Related Groups) would not be likely to keep a patient
hospitalised longer than necessary.
Critics of managed care are worried that in contrast to the fee-for-service
method of provider reimbursement, capitation and DRGs would lead  instead to
undertreatment of patients. This problem can be reduced through programmes of
quality assurance, allowing enrollees to change providers, third party review of
medical decisions and competition between MCOs for large groups of enrollees
(Davis et al. 1990).
COST CONTROL
Mechanisms of cost control found in managed care include cost-sharing with
healthcare consumers and risk-sharing with healthcare providers.  Cost-sharing
includes things like co-payments, deductibles and  co-insurance. In the case of drugs,
a three-tier system can be designed such that there is minimal co-payment for generic
drugs, a moderate co-payment for branded, formulary drugs, and a high co-payment
for branded, non-formulary drugs (Mavrogordato and Featherstone, 1999).
Part of the financial risks will be borne by providers when they are prepaid for
contracted services (regardless of the level of healthcare services provided eventually
to their enrollees).  Similarly, reimbursement for in-patient care based on DRGs
would transfer some of the financial risk to the hospitals.
In the case of PPOs (Preferred Provider Organisations) which continue to use
the fee-for-service system to reimburse providers, negotiated fee schedules are used
to lower the cost of healthcare.
In managed care, alternatives to in-hospital care are used whenever possible.
These include treatment outside the hospital, ambulatory care, day surgery and active
monitoring of hospital stays. In fact, researchers have concluded that managed care
has reduced costs mainly through lower rates of hospital admissions and shorter
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lengths of stay in the hospital (Luft, 1981)(Manning et al. 1984)(Robinson and
Steiner, 1998).
EXPERIENCE WITH MANAGED CARE IN SINGAPORE
The author’s actual experience gained from managing Singapore’s first MCO
indicates that employers are very interested in managed care. However, the response
from their employees tend to be less positive. Providers typically react to the
introduction of managed care with apprehension or even strong resistance.
Employers are interested in managed care because a contract with an MCO
enables them to calculate the costs of healthcare benefits for their employees in
advance. However, employees are unsure about managed care because they are not in
favour of co-payments and generic drugs. They also dislike what they perceive as
restriction of access to doctors. The latter is a misperception in the sense that most
employees actually  visit only one provider (their GP) for routine care and MCOs
may even allow them to choose two primary care providers, i.e., a GP clinic near the
home and another GP clinic near their workplace (NTUC INCOME Insurance Co-
operative Limited, Managed Healthcare System).
Primary care providers are used to the fee-for-service method of
reimbursement and fail to appreciate that under capitation, they are paid a fixed
monthly fee per enrollee on their list even if the enrollees never seek treatment from
them at all during the month. Furthermore, they may even be paid an additional
“chronic disease capitation” fee for patients who are affected by chronic disease.
EXPERIENCE WITH MANAGED CARE IN AMERICA
Managed care is most highly developed in the United States. It has been shown to be
effective in controlling costs. As compared to unmanaged care, it has led to fewer
hospital admissions and shorter hospital stays (Manning et al., 1984). It has also
resulted in much lower usage of expensive medical procedures, procedures of
unproven efficacy, and procedures for which less expensive alternatives exist (Miller
and Luft, 1994)(Robinson and Steiner, 1998).
The big debate in the United States is over the question of whether managed
care results in deterioration in the quality of care. Recently, Robinson and Steiner
carried out a comprehensive review of the literature on this important question for the
British Government (Robinson and Steiner, 1998). They concluded that: Structural
quality of care (access to treatment, continuity of care, professional training levels) is
no different in managed care as compared to care provided under the fee-for-service
system.
However, MCO enrollees had significantly less access to treatment than fee-
for-service patients. Findings on process quality of care (the extent to which
treatment patterns satisfy pre-established standards) are inconsistent. From 23 studies
and 146 observations (variables), 20% indicate better treatment under fee-for-service,
36% indicate better treatment under managed care and 44% revealed no significant
differences.MCO enrollees tended to be less satisfied than fee-for-service enrollees
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for various reasons Nevertheless, health outcomes were virtually the same in both
systems of care.
Robinson and Steiner also concluded that although “Managed care is
associated with rather more frequent visits to physicians …. an important exception
is for mental health visits, where MCO patients receive less – and less specialized –
treatment” (Robinson and Steiner, 1998).
A recent study comparing investor-owned and nonprofit MCOs concluded that
the quality of care in the former is lower than that in the latter. Investor-owned
MCOs scored lower on all of the 14 quality-of-care indicators used in the study
(Himmelstein et al. 1999). Further research is needed on this topic because most
previous research on quality of care in MCOs has focused on nonprofit organisations.
CONCLUSION: IMPLICATIONS FOR MALAYSIA
Managed care has not taken off in Singapore. However, it is now the dominant mode
of organisation of healthcare services in the United States. Managed care is quite new
to Malaysia as it was introduced into this country only during the middle 1990s
(Pilus, 1999). The future growth of managed care in Malaysia is likely to depend on a
number of factors. These include:
Whether GP care continues to remain affordable to most Malaysians Whether
the Malaysian Government continues to provide heavily subsidised outpatient and
inpatient services to the public Whether more and more major employers decide to
sign contracts with MCOs to provide care for their employees Whether barriers to
penetration of the Malaysian market for healthcare services by foreign MCOs
continue to remain significant
It is likely that GP care will continue to remain affordable to most Malaysians
because the market for GP services is quite competitive.
This is especially true in the case of the larger Malaysian cities and towns
where GPs tend to cluster.
The Malaysian Government may reactivate its policy of corporatisation and
privatisation of public healthcare facilities and services (Chan, 1996).  It may also
reduce the level of subsidy for outpatient and inpatient care as well as for
pharmaceuticals. These would lead to higher charges for patients and probably
encourage the growth of private health insurance and managed care.
As to the question of whether more and more large employers would sign contracts
with MCOs, this may depend on the response of the Malaysian Trades Union
Congress and workers to managed care. The Singaporean experience indicates that
employees are unlikely to greet the concept of  cost-sharing through co-payment with
any enthusiasm. It will also take time for employees to accept the idea that generic
drugs can be safely and effectively prescribed in place of more expensive branded
drugs.
If foreign managed care organisations are allowed to operate freely in
Malaysia, e.g., including the right to buy existing (or to set up new) hospitals and
healthcare facilities, this would strengthen the presence of managed care in the
country.
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Provider resistance is unlikely to be a major factor in affecting the growth of
managed care (unlike globalisation, market forces and the rise of what Paul Starr has
called “corporate medicine”) (Starr, 1982). This is because some providers may
actually gain by participating in managed care although their professional autonomy
will be reduced to some extent. Managed care will strengthen the position of GPs vis-
à-vis specialists because of its emphasis on primary care and its emphasis on GPs as
gatekeepers to more expensive care. Furthermore, providers who move into
management positions in MCOs will also gain in terms of power and influence.
Whatever the future of managed care in Malaysia, certain innovations arising
from the managed care movement in America can possibly be considered for
adoption in Malaysia (Robinson and Steiner, 1998:19-26)(Mavrogordato and
Featherstone, 1999) (Geraty, 1999). This is especially true in the case of the public
sector: although this sector is not profit-oriented, it can attempt to increase its cost-
effectiveness and efficiency using managed care innovations. These innovations can
be grouped into two categories – “less controversial” and “more controversial”.
The less controversial innovations include:
. self-care by patients
. co-payments to discourage unnecessary utilisation
. no or minimal co-payment charges for preventive care
. queuing and other forms of rationing for elective care
. case management (for complicated cases)
. clinical practice guidelines and evidence-based medicine
. control of access to new technologies and expensive procedures
. formulary and generic drugs
. teleconsultations (to reduce unnecessary referrals)
More controversial innovations include:
. financial risk-sharing by providers
. utilisation review (pre-admission review, concurrent review, and
  retrospective review)
. medical practice profiling
. mandatory second opinions
. management of pharmacy benefits, imaging management etc.
. greater use of “physician extenders” such as medical assistants for
  routine care, nurse midwives for normal deliveries and so on
Lastly, it must be pointed out that there should be proper regulation of MCOs
in Malaysia by the Government. For example, there can be mandated standards
which MCOs have to meet in order to be allowed to operate, e.g., in terms of
facilities, staffing, range of services provided etc. There can also be open enrolment
periods, a proper appeals process and independent review of disputed decisions. All
these actions would help to protect the welfare of MCO enrollees (Davis et al., 1990).
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